Body mass index and weight change in relation to triple-negative breast cancer survival

Cancer Causes and Control

Volumn 27, Issue 2, 2016, Pages 229-236

  Bao, Ping Ping ^a   Cai, Hui ^b   Peng, Peng ^a   Gu, Kai ^a   Su, Yinghao ^b   Shu, Xiao Ou ^b   Zheng, Ying ^a  

^a SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Body mass index; Prognosis; Survival outcomes; Triple negative breast cancer; Weight change

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG USE; EDUCATIONAL STATUS; FEMALE; FOOD INTAKE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MIDDLE AGED; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEA; TRIPLE NEGATIVE BREAST CANCER; WAIST HIP RATIO; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; AGED; BODY WEIGHT; COMORBIDITY; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TRIPLE NEGATIVE BREAST NEOPLASMS;

ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; CHINA; COHORT STUDIES; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; OBESITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TRIPLE NEGATIVE BREAST NEOPLASMS; WEIGHT GAIN; WEIGHT LOSS;

EID: 84958169374     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0700-7     Document Type: Article

References (34)

1. Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE, Kolonel LN (2011) Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study. Breast Cancer Res Treat 129:565–574
2. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635
3. Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH (2013) Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol 24:2506–2514
4. Kwan ML, Chen WY, Kroenke CH et al (2012) Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat 132:729–739
5. Azrad M, Demark-Wahnefried W (2014) The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep 3:9–15
6. Chan DS, Vieira AR, Aune D et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 25:1901–1914
7. Boyle P (2012) Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol 23(Suppl 6):vi7–vi12
8. Ademuyiwa FO, Groman A, O’Connor T, Ambrosone C, Watroba N, Edge SB (2011) Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer 117:4132–4140
9. Sparano JA, Wang M, Zhao F et al (2012) Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118:5937–5946
10. Mowad R, Chu QD, Li BD, Burton GV, Ampil FL, Kim RH (2013) Does obesity have an effect on outcomes in triple-negative breast cancer? J Surg Res 184:253–259
11. Tait S, Pacheco JM, Gao F, Bumb C, Ellis MJ, Ma CX (2014) Body mass index, diabetes, and triple-negative breast cancer prognosis. Breast Cancer Res Treat 146:189–197
12. Dawood S, Lei X, Litton JK, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM (2012) Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. Clin Breast Cancer 12:364–372
13. Pajares B, Pollan M, Martin M et al (2013) Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis. Breast Cancer Res 15:R105
14. Turkoz FP, Solak M, Petekkaya I et al (2013) The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. J BUON 18:335–341
15. Makari-Judson G, Braun B, Jerry DJ, Mertens WC (2014) Weight gain following breast cancer diagnosis: implication and proposed mechanisms. World J Clin Oncol 5:272–282
16. Nichols HB, Trentham-Dietz A, Egan KM et al (2009) Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev 18:1403–1409
17. Thivat E, Therondel S, Lapirot O et al (2010) Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 10:648
18. Bradshaw PT, Ibrahim JG, Stevens J et al (2012) Postdiagnosis change in bodyweight and survival after breast cancer diagnosis. Epidemiology 23:320–327
19. Chen X, Lu W, Zheng W et al (2010) Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 122:823–833
20. Caan BJ, Kwan ML, Shu XO et al (2012) Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 21:1260–1271
21. Jeon YW, Lim ST, Choi HJ, Suh YJ (2014) Weight change and its impact on prognosis after adjuvant TAC (docetaxel–doxorubicin–cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer. Med Oncol 31:849
22. Caan BJ, Kwan ML, Hartzell G et al (2008) Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 19:1319–1328
23. Shu XO, Zheng Y, Cai H et al (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443
24. Epplein M, Zheng Y, Zheng W et al (2011) Quality of life after breast cancer diagnosis and survival. J Clin Oncol 29:406–412
25. Su Y, Zheng Y, Zheng W et al (2011) Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer 11:292
26. Matthews CE, Shu XO, Yang G et al (2003) Reproducibility and validity of the Shanghai Women’s Health Study physical activity questionnaire. Am J Epidemiol 158:1114–1122
27. Grunau GL, Sheps S, Goldner EM, Ratner PA (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59:274–280
28. Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80
29. Rock CL, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20:3302–3316
30. Demark-Wahnefried W, Campbell KL, Hayes SC (2012) Weight management and its role in breast cancer rehabilitation. Cancer 118:2277–2287
31. Cole SW (2009) Chronic inflammation and breast cancer recurrence. J Clin Oncol 27:3418–3419
32. Oh SW, Park CY, Lee ES et al (2011) Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res 13:R34
33. Dodson S, Baracos VE, Jatoi A et al (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62:265–279
34. Zauderer M, Patil S, Hurria A (2009) Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer. Breast Cancer Res Treat 117:205–210